Cas:1256360-57-2 N-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]cyclopentanamine manufacturer & supplier

We serve Chemical Name:N-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]cyclopentanamine CAS:1256360-57-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]cyclopentanamine

Chemical Name:N-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]cyclopentanamine
CAS.NO:1256360-57-2
Synonyms:X0491;2-(Cyclopentylaminomethyl)phenylboronic acid pinacol ester;N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine
Molecular Formula:C18H28BNO2
Molecular Weight:301.23100
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:30.49000
Exact Mass:301.22100
LogP:3.40890

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like X0491 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(Cyclopentylaminomethyl)phenylboronic acid pinacol ester Use and application,N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine technical grade,usp/ep/jp grade.


Related News: in addition to standard therapy. The trial did not meet its primary endpoint based on the SLE Responder Index 4 (SRI4) composite measure. Benzene, 1,1′-methylenebis[3,5-dimethyl-4-(2-propynyloxy)- manufacturers A multitude of enzymes is now utilized for generating active pharmaceutical ingredients (APIs) and intermediates for their production, with such reagents offering numerous advantages compared to using traditional metal catalysts. Acetic acid 3-(4-methoxy-phenyl)-1-[2-(4-methoxy-phenyl)-ethyl]-propyl ester suppliers The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. Threonine, L-valyl-4-[(3S,5S)-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-3-yl]- vendor & factory.